Aug 10, 2026 09:10AM

Aug 6, 2024 04:05PM

Jul 31, 2024 09:01AM

Jul 31, 2024 09:00AM

Nov 30, 2022 02:54PM

Jun 29, 2022 11:04AM

Feb 14, 2022 05:43AM AbCellera's (ABCL) Bebtelovimab Granted FDA Emergency Use Authorization for the Treatment of Mild-to-Moderate COVID-19

Feb 11, 2022 03:37PM

Feb 11, 2022 03:37PM

Feb 11, 2022 03:37PM

Feb 11, 2022 05:31AM

Feb 10, 2022 07:40PM

Dec 3, 2021 04:05PM

Dec 3, 2021 04:05PM AbCellera-Discovered Bamlanivimab Together with Etesevimab Authorized as the First and Only Antibody Therapy for Emergency Use in COVID-19 Patients Under the Age of 12

Nov 9, 2021 04:05PM

Nov 2, 2021 04:04PM

Sep 21, 2021 01:56PM

Sep 21, 2021 01:55PM

Sep 20, 2021 07:10AM

Sep 17, 2021 09:28AM

Sep 16, 2021 05:56PM After-Hours Stock Movers 09/16: (ABCL) (FANG) Higher; (GRTS) (X) Lower (more...)

Sep 16, 2021 04:42PM

Sep 16, 2021 04:19PM

Sep 16, 2021 04:15PM

Aug 18, 2021 09:00AM

Jun 22, 2021 09:02AM

Jun 22, 2021 09:00AM

May 14, 2021 09:30AM Pre-Open Stock Movers 05/14: (BNGO) (PLUG) (FSR) Higher; (CRMD) (PLT) (ABCL) Lower (more...)

May 4, 2021 06:30AM

Apr 5, 2021 02:01PM

Apr 5, 2021 02:00PM

Mar 30, 2021 09:21AM

Mar 10, 2021 11:22AM

Mar 10, 2021 11:21AM

Mar 5, 2021 03:33PM AbCellera (ABCL) Says EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

Mar 5, 2021 03:30PM

Feb 11, 2021 04:05PM

Feb 9, 2021 08:26PM

Jan 27, 2021 07:26AM

Jan 27, 2021 07:22AM

Jan 26, 2021 07:10AM

Jan 26, 2021 07:09AM AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%

Jan 21, 2021 08:28AM

Jan 21, 2021 08:27AM

Dec 21, 2020 09:03AM

Dec 21, 2020 09:00AM

327,908 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All